We are live on ! Find out more
EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC

Delisted

EBAC was delisted on the 2nd of March, 2023.

Back to rankings

31 hedge funds and large institutions have $40.2M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
–
Reduced
–
Closed
–
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
+$14K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$6.14M
2
LA
Linden Advisors
New York
+$4.89M
3
Marshall Wace
Marshall Wace
United Kingdom
+$3.2M
4
SCM
Suvretta Capital Management
New York
+$2.95M
5
WP
Woodline Partners
California
+$2.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$322K +$327K +33,333 New
WRBC
27
W.R. Berkley Corp
Connecticut
$190K +$193K +19,650 New
PCM
28
Prelude Capital Management
New York
$97K +$98.2K +10,000 New
AA
29
Ancora Advisors
Ohio
$68K +$68.8K +7,000 New
MI
30
MMCAP International
Cayman Islands
$2.44K +$2.46M +250,000 New
GCL
31
Glazer Capital LLC
New York
– +$363 +37 New
1
2

EBAC Hedge Fund Activity: Q2 2021 in Review

31 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) for Q2 2021, worth a combined $40.2M.

Buyers outnumbered sellers: 31 funds opened new EBAC positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $6.14M.

  • 31 institutional investors held European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $40.2M of European Biotech Acquisition Corp. Class A Ordinary Shares stock for Q2 2021.
  • 31 funds opened new European Biotech Acquisition Corp. Class A Ordinary Shares positions in Q2 2021 and 0 closed out, a net change of +31 holders.
  • The largest European Biotech Acquisition Corp. Class A Ordinary Shares buyer in Q2 2021 was Citadel Advisors, an estimated $6.14M added.

Based on aggregated 13F filings for Q2 2021.